BROOKFIELD ASSET MGMT-A (BAM)

CA1130041058 - Common Stock

55.56  +0.56 (+1.02%)

After market: 55.56 0 (0%)

Fundamental Rating

4

BAM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 218 industry peers in the Capital Markets industry. Both the profitability and the financial health of BAM get a neutral evaluation. Nothing too spectacular is happening here. BAM is quite expensive at the moment. It does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

BAM had positive earnings in the past year.
In the past year BAM had a positive cash flow from operations.
In the past 5 years BAM has always been profitable.
Of the past 5 years BAM 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 10.59%, BAM belongs to the top of the industry, outperforming 88.37% of the companies in the same industry.
Looking at the Return On Equity, with a value of 13.72%, BAM is in the better half of the industry, outperforming 73.49% of the companies in the same industry.
BAM has a worse Return On Invested Capital (1.18%) than 75.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BAM is below the industry average of 6.96%.
Industry RankSector Rank
ROA 10.59%
ROE 13.72%
ROIC 1.18%
ROA(3y)7.32%
ROA(5y)4.86%
ROE(3y)13.82%
ROE(5y)10.26%
ROIC(3y)3.33%
ROIC(5y)N/A

1.3 Margins

BAM's Profit Margin of 113.59% is amongst the best of the industry. BAM outperforms 98.60% of its industry peers.
In the last couple of years the Profit Margin of BAM has grown nicely.
BAM's Operating Margin of 13.33% is on the low side compared to the rest of the industry. BAM is outperformed by 67.44% of its industry peers.
BAM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.33%
PM (TTM) 113.59%
GM N/A
OM growth 3Y-40.15%
OM growth 5Y-3.5%
PM growth 3Y85.4%
PM growth 5Y79.53%
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BAM has been reduced compared to 1 year ago.
Compared to 5 years ago, BAM has less shares outstanding
The debt/assets ratio for BAM is higher compared to a year ago.

2.2 Solvency

BAM has an Altman-Z score of 15.54. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BAM (15.54) is better than 98.14% of its industry peers.
BAM has a debt to FCF ratio of 0.43. This is a very positive value and a sign of high solvency as it would only need 0.43 years to pay back of all of its debts.
The Debt to FCF ratio of BAM (0.43) is better than 90.23% of its industry peers.
BAM has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
BAM has a better Debt to Equity ratio (0.07) than 83.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.43
Altman-Z 15.54
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.84 indicates that BAM may have some problems paying its short term obligations.
With a Current ratio value of 0.84, BAM is not doing good in the industry: 60.47% of the companies in the same industry are doing better.
BAM has a Quick Ratio of 0.84. This is a bad value and indicates that BAM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.84, BAM is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.68% over the past year.
Measured over the past years, BAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.79% on average per year.
The Revenue has grown by 935.14% in the past year. This is a very strong growth!
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -63.20% yearly.
EPS 1Y (TTM)3.68%
EPS 3Y4.81%
EPS 5Y-9.79%
EPS Q2Q%8.57%
Revenue 1Y (TTM)935.14%
Revenue growth 3Y-43.77%
Revenue growth 5Y-63.2%
Sales Q2Q%25.08%

3.2 Future

BAM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.85% yearly.
Based on estimates for the next years, BAM will show a quite strong growth in Revenue. The Revenue will grow by 12.50% on average per year.
EPS Next Y5.5%
EPS Next 2Y12.16%
EPS Next 3Y13.85%
EPS Next 5YN/A
Revenue Next Year5.41%
Revenue Next 2Y11.75%
Revenue Next 3Y12.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 39.40, BAM can be considered very expensive at the moment.
76.28% of the companies in the same industry are cheaper than BAM, based on the Price/Earnings ratio.
BAM is valuated rather expensively when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 32.24 indicates a quite expensive valuation of BAM.
BAM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BAM is more expensive than 73.02% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BAM to the average of the S&P500 Index (23.82), we can say BAM is valued slightly more expensively.
Industry RankSector Rank
PE 39.4
Fwd PE 32.24

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAM is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 48.68
EV/EBITDA 373.83

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BAM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BAM's earnings are expected to grow with 13.85% in the coming years.
PEG (NY)7.16
PEG (5Y)N/A
EPS Next 2Y12.16%
EPS Next 3Y13.85%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.31%.
BAM's Dividend Yield is comparable with the industry average which is at 9.01.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.23.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

BAM has been paying a dividend for at least 10 years, so it has a reliable track record.
BAM has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

126.64% of the earnings are spent on dividend by BAM. This is not a sustainable payout ratio.
DP126.64%
EPS Next 2Y12.16%
EPS Next 3Y13.85%

BROOKFIELD ASSET MGMT-A

NYSE:BAM (11/21/2024, 8:14:04 PM)

After market: 55.56 0 (0%)

55.56

+0.56 (+1.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap24.68B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 39.4
Fwd PE 32.24
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)7.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.59%
ROE 13.72%
ROCE
ROIC
ROICexc
ROICexgc
OM 13.33%
PM (TTM) 113.59%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.68%
EPS 3Y4.81%
EPS 5Y
EPS Q2Q%
EPS Next Y5.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)935.14%
Revenue growth 3Y-43.77%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y